Binnacle Investments Inc Bristol Myers Squibb CO Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
A detailed history of Binnacle Investments Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Binnacle Investments Inc holds 1,539 shares of BMY stock, worth $74,149. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,539Holding current value
$74,149% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,813Shares Held
1.6BCall Options Held
29.6MPut Options Held
28.2M-
Vanguard Group Inc Valley Forge, PA191MShares$9.22 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.64 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.21 Billion0.52% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.58 Billion0.22% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.2 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $102B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...